Mutually informed by each other’s work, and based on the strength of Raskind’s studies and now several large-scale independent clinical trials, prazosin has become the officially approved drug by the VA for the treatment of repetitive trauma nightmares, and has since received approval by the US Food and Drug Administration for the same benefit.
